Citi upgraded Fortrea (FTRE) to Buy from Neutral with a price target of $21, up from $12. The firm adjusted ratings in the life science tools and diagnostics group as part of its 2026 outlook. It believes Fortrea is well positioned for margin expansion and upside to consensus estimates.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FTRE: